The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

被引：35
|
作者：
Temian, Daiana Cosmina [1 ,2 ]
Pop, Laura Ancuta [1 ]
Irimie, Alexandra Iulia [3 ]
Berindan-Neagoe, Ioana [1 ,4 ,5 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Prosthet Dent & Dent Mat, Div Dent Propaedeut, Aesthet, 23 Marinescu St, Cluj Napoca 40015, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, MedFUTURE Res Ctr Adv Med, Cluj Napoca, Romania
[5] Oncol Inst Prof Dr I Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania
来源：
JOURNAL OF BREAST CANCER | 2018年 / 21卷 / 03期
关键词：
Breast neoplasms; DNA methylation; Histone code; Triple negative breast neoplasms; Untranslated RNA; LONG NONCODING RNAS; HISTONE DEACETYLASE INHIBITORS; PREDICTS SENSITIVITY; MOLECULAR PORTRAITS; DOWN-REGULATION; AXON GUIDANCE; MUTANT P53; EXPRESSION; IDENTIFICATION; BROMODOMAIN;
D O I：
10.4048/jbc.2018.21.e41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies-the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis-DNA methylation, histone modifications, and noncoding RNAs-advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.
引用
收藏
页码：233 / +
页数：16
相关论文
共 50 条
  • [41] Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
    Niwinska, Anna
    Olszewski, Wojciech
    Murawska, Magdalena
    Pogoda, Katarzyna
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 547 - 553
  • [42] BRCAness and PD-L1 expression of basal-like and not basal-like triple negative breast cancer
    Mori, H.
    Kubo, M.
    Yamada, M.
    Kai, M.
    Osako, T.
    Nishimura, R.
    Arima, N.
    Okido, M.
    Kuroki, S.
    Oda, Y.
    Nakamura, M.
    CANCER RESEARCH, 2016, 76
  • [43] Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells
    Yunokawa, Mayu
    Koizumi, Fumiaki
    Kitamura, Yuka
    Katanasaka, Yasufumi
    Okamoto, Naoko
    Kodaira, Makoto
    Yonemori, Kan
    Shimizu, Chikako
    Ando, Masashi
    Masutomi, Kenkichi
    Yoshida, Teruhiko
    Fujiwara, Yasuhiro
    Tamura, Kenji
    CANCER SCIENCE, 2012, 103 (09) : 1665 - 1671
  • [44] Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
    Olsson, Maxim
    Larsson, Peter
    Johansson, Junko
    Sah, Vasu R.
    Parris, Toshima Z.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [45] Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer
    Limsakul, Praopim
    Choochuen, Pongsakorn
    Jungrungrueang, Thawirasm
    Charupanit, Krit
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [46] Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
    Min Wu
    Keyu Yuan
    Shuzhen Lyu
    Yanping Li
    World Journal of Surgical Oncology, 20
  • [47] Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
    Thike, Aye Aye
    Chong, Luke Yong-Zheng
    Cheok, Poh Yian
    Li, Hui Hua
    Yip, George Wai-Cheong
    Bay, Boon Huat
    Tse, Gary Man-Kit
    Iqbal, Jabed
    Tan, Puay Hoon
    MODERN PATHOLOGY, 2014, 27 (03) : 352 - 360
  • [48] LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
    Lo, Pang-Kuo
    Yao, Yuan
    Lee, Ji Shin
    Zhang, Yongshu
    Huang, Weiliang
    Kane, Maureen A.
    Zhou, Qun
    ELIFE, 2018, 7
  • [49] Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
    Wu, Min
    Yuan, Keyu
    Lyu, Shuzhen
    Li, Yanping
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [50] Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
    Bas Kreike
    Marieke van Kouwenhove
    Hugo Horlings
    Britta Weigelt
    Hans Peterse
    Harry Bartelink
    Marc J van de Vijver
    Breast Cancer Research, 9
12345